Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Ascend Laboratories, LLC recalls Dabigatran etexilate Capsules

Class IIIofficial

FDA Class III

FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).

Hazard
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.
Products
  • Dabigatran etexilate Capsules
Where it was sold

USA Nationwide

Nationwide

Units affected
2,717 cartons
About this recall
Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7255-10.